Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 256

1.

Capsular types and antibiotic susceptibility of pneumococci isolated from patients in Belgium with serious infections, 1980-1993.

Verhaegen J, Glupczynski Y, Verbist L, Blogie M, Verbiest N, Vandeven J, Yourassowsky E.

Clin Infect Dis. 1995 May;20(5):1339-45.

PMID:
7620021
2.

The effect of clindamycin gel insert in periodontal pockets, as observed on smears and cultures.

Sauvêtre E, Glupczynsky Y, Labbé M, Yourassowsky E, Pourtois M.

Infection. 1993 Jul-Aug;21(4):245-7.

PMID:
8225629
3.

[Trends in pneumococcal infections in Belgium from 1986 to 1991].

Ducoffre G, Walckiers D, Glupczynski Y, Verbist L, Verhaegen J, Yourassowsky E.

Acta Clin Belg. 1993;48(3):148-55. French.

PMID:
8396296
4.

Susceptibility of anaerobic microorganisms to hypothiocyanite produced by lactoperoxidase.

Courtois P, Majerus P, Labbé M, Vanden Abbeele A, Yourassowsky E, Pourtois M.

Acta Stomatol Belg. 1992 Sep;89(3):155-62.

PMID:
1481764
6.
7.

Resistance to amoxicillin/clavulanate in Escherichia coli.

Glupczynski Y, Mac Gillavry G, Yourassowsky E.

Acta Clin Belg. 1992;47(5):354-5. No abstract available.

PMID:
1334325
8.

[Is there in Belgium an increase in resistance to the combination amoxicillin/clavulanic acid of Escherichia coli as reference bacteria?].

Yourassowsky E, Van der Linden MP, MacGilavry GB, Glupczynsky Y.

Acta Clin Belg. 1992;47(1):15-20. French.

PMID:
1317079
9.

Evaluation of the E test for quantitative antimicrobial susceptibility testing of Helicobacter pylori.

Glupczynski Y, Labbé M, Hansen W, Crokaert F, Yourassowsky E.

J Clin Microbiol. 1991 Sep;29(9):2072-5.

10.

A sentinel network of microbiological laboratories as a tool for surveillance of infectious diseases in Belgium.

Walckiers D, Stroobant A, Yourassowsky E, Lion J, Cornelis R.

Epidemiol Infect. 1991 Apr;106(2):297-303.

11.

Gas-liquid chromatographic analysis of cellular fatty acid methyl esters in Aeromonas species.

Hansen W, Freney J, Labbe M, Renaud F, Yourassowsky E, Fleurette J.

Zentralbl Bakteriol. 1991 Apr;275(1):1-10.

PMID:
1930556
12.

Cellular fatty acid composition of Acinetobacter strains.

Hansen W, Yourassowsky E.

Microbios. 1991;65(264-265):195-203.

PMID:
2030649
13.

Antibacterial effects of meropenem and imipenem against Haemophilus influenzae.

Yourassowsky E, Van der Linden MP, Crokaert F.

Chemotherapy. 1991;37(1):38-42.

PMID:
2013240
14.

Antibacterial effect of meropenem and imipenem on Proteus mirabilis.

Yourassowsky E, Van der Linden MP, Crokaert F.

J Antimicrob Chemother. 1990 Aug;26(2):185-92.

PMID:
2211455
15.

Capsular types and antibiotic sensitivity of pneumococci isolated from patients with serious infections in Belgium 1980 to 1988.

Verhaegen J, Glupczynski Y, Verbist L, Blogie M, Vandeven J, Yourassowsky E, Vandepitte J.

Eur J Clin Microbiol Infect Dis. 1990 Jun;9(6):390-5.

PMID:
2387291
16.

Inoculum effect on growth-delay time of oxacillin-resistant strains of Staphylococcus aureus and Staphylococcus epidermidis exposed to cefamandole, cefazolin, and cefuroxime.

Yourassowsky E, van der Linden MP, Crokaert F.

Antimicrob Agents Chemother. 1990 Apr;34(4):505-9. Erratum in: Antimicrob Agents Chemother 1990 Aug;34(8):1622.

17.

Turbidimetric and microscopic analysis of Bacteroides fragilis exposed to tazobactam and piperacillin alone and in combination.

Yourassowsky E, Van der Linden MP, Lismont MJ, Crokaert F.

Chemotherapy. 1990;36(3):215-21.

PMID:
2159865
18.

One shot of high-dose amikacin: a working hypothesis.

Yourassowsky E, Van der Linden MP, Crokaert F.

Chemotherapy. 1990;36(1):1-7.

PMID:
2106415
19.

Bactericidal activity of meropenem against Pseudomonas aeruginosa.

Yourassowsky E, Van der Linden MP, Lismont MJ, Crokaert F, Glupczynski Y.

J Antimicrob Chemother. 1989 Sep;24 Suppl A:169-74.

PMID:
2509414
20.

Growth Curve Patterns of Escherichia coli, Serratia marcescens, and Proteus vulgaris Submitted to Different Tigemonam Concentrations.

Yourassowsky E, Linden MP, Lismont MJ, Crokaert F.

J Chemother. 1989 May;1(sup2):49-53.

PMID:
27416151
21.

Growth curve patterns of Escherichia coli, Serratia marcescens, and Proteus vulgaris submitted to different tigemonam concentrations.

Yourassowsky E, van der Linden MP, Lismont MJ, Crokaert F.

J Chemother. 1989 May;1 Suppl 2:49-53.

PMID:
2681561
22.

In vitro activity of timentin against community and hospital-acquired gram-negative bacterial isolates.

Glupczynski Y, McGillavry G, Yourassowsky E.

Acta Clin Belg. 1989;44(1):66-7. No abstract available.

PMID:
2788344
23.

Correlation between the growth and killing curves of Escherichia coli in the presence of cefotetan or piperacillin.

Yourassowsky E, Van der Linden MP, Lismont MJ, Crokaert F, Glupczynski Y.

Chemotherapy. 1989;35(1):12-6.

PMID:
2656117
24.

Correlation between growth curves and killing curves of Escherichia coli in the presence of fleroxacin and ampicillin.

Yourassowsky E, Van der Linden MP, Crokaert F.

Chemotherapy. 1989;35(6):423-30.

PMID:
2515040
25.

Protective effect of amdinocillin against emergence of resistance to ceftazidime in Enterobacter cloacae.

Yourassowsky E, van der Linden MP, Lismont MJ, Crokaert F, Glupczynski Y.

Antimicrob Agents Chemother. 1988 Nov;32(11):1632-5.

26.

Rate of bactericidal activity for Branhamella catarrhalis of fleroxacin compared with that of amoxycillin-clavulanic acid.

Yourassowsky E, Van der Linden MP, Lismont MJ, Crokaert F, Glupczynski Y.

J Antimicrob Chemother. 1988 Oct;22 Suppl D:43-7.

PMID:
3144548
27.

Determination of serum bactericidal activity against Escherichia coli by an automated photometric method.

Crokaert F, Lismont MJ, van der Linden MP, Yourassowsky E.

J Clin Microbiol. 1988 Oct;26(10):2069-76.

28.

Bactericidal activity of BMY-28100 versus amoxicillin/clavulanic acid against Branhamella catarrhalis.

Yourassowsky E, Van der Linden MP, Lismont MJ, Crokaert F.

Eur J Clin Microbiol Infect Dis. 1988 Jun;7(3):433-4. No abstract available.

PMID:
3137055
29.

Penetration of aminoglycosides in uninfected pleural exudates and in pleural empyemas.

Thys JP, Vanderhoeft P, Herchuelz A, Bergmann P, Yourassowsky E.

Chest. 1988 Mar;93(3):530-2.

PMID:
3342660
30.

In vitro susceptibility of Alcaligenes denitrificans subsp. xylosoxidans to 24 antimicrobial agents.

Glupczynski Y, Hansen W, Freney J, Yourassowsky E.

Antimicrob Agents Chemother. 1988 Feb;32(2):276-8.

31.

Enoxacin in acute exacerbations of chronic bronchitis: a comparison with amoxycillin.

Prigogine T, Glupczynski Y, Carpiaux JP, Blogie M, Yourassowsky E, Schmerber JS.

J Antimicrob Chemother. 1988 Feb;21 Suppl B:131-6.

PMID:
3129390
32.

Comparative in vitro activity of augmentin against community and hospital-acquired gram-negative bacteria.

Glupczynski Y, McGillavry G, Yourassowsky E.

Acta Clin Belg. 1988;43(2):109-14. No abstract available.

PMID:
3400375
33.

[Prospective considerations on the dose-effect relationship in antibiotic therapy].

Yourassowsky E.

Ann Biol Clin (Paris). 1988;46(2):138-43. French.

PMID:
3382064
34.

Effect of antibiotics carry-over on bacterial counting by 'spiral plating'.

Yourassowsky E, Van der Linden MP, Crokaert F, Glupczynski Y.

J Antimicrob Chemother. 1988 Jan;21(1):138-40. No abstract available. Erratum in: J Antimicrob Chemother 1988 Jun;21(6):813.

PMID:
3356621
35.

Bactericidal effect and regrowth of Streptococcus faecalis exposed to amoxicillin following beta-lactamase.

Yourassowsky E, Van der Linden MP, Lismont MJ, Crockaert F, Glupczynski Y.

Chemotherapy. 1988;34(6):462-6.

PMID:
3149569
36.

Temocillin: comparative in vitro activity against gram-negative clinical isolates.

Glupczynski Y, McGlillavry G, Yourassowsky E.

Acta Clin Belg. 1988;43(3):194-8. No abstract available.

PMID:
3137759
37.

Rate of bactericidal activity for Branhamella catarrhalis of a new macrolide, CP-62,993, compared with that of amoxicillin-clavulanic acid.

Yourassowsky E, van der Linden MP, Lismont MJ, Crokaert F, Glupczynski Y.

Chemotherapy. 1988;34(3):191-4.

PMID:
2843324
38.

Selection and counting of aerobic gram-negative bacilli in saliva by the spiral system.

Yourassowsky E, Van der Linden MP, Pardaens Y, Crokaert F, Glupczynski Y.

Eur J Clin Microbiol. 1987 Dec;6(6):634-6.

PMID:
3440455
39.

Detection of Gardnerella vaginalis in vaginal specimens by direct immunofluorescence.

Hansen W, Vray B, Miller K, Crokaert F, Yourassowsky E.

J Clin Microbiol. 1987 Oct;25(10):1934-7.

40.

[Measure by turbidimetry and bactericidal effect of the speed of action of clavulanic acid, amoxicillin and their combinations on a Haemophilus influenzae producer of beta-lactamase].

Yourassowsky E, Van der Linden MP, Lismont MJ, Crokaert F, Glupczynski Y.

Pathol Biol (Paris). 1987 May;35(5):526-30. French.

PMID:
3302856
41.

[Infectious diseases of the respiratory tract and their treatment].

Yourassowsky E.

Rev Med Brux. 1987 Mar;8(3):145-6. French. No abstract available.

PMID:
3589260
42.

Determining the minimum inhibitory concentration of beta-lactam antibiotics for Haemophilus influenzae: a problem.

Yourassowsky E, Van der Linden MP, Lismont MJ, Crokaert F, Glupczynski Y.

J Antimicrob Chemother. 1987 Feb;19(2):274-5. No abstract available.

PMID:
3494721
43.

Effect on growth curves and killing curves of brief exposure of Escherichia coli to imipenem and piperacillin.

Yourassowsky E, Van der Linden MP, Lismont MJ, Crokaert F, Glupczynski Y.

J Antimicrob Chemother. 1986 Dec;18 Suppl E:61-5.

PMID:
3546248
44.

Rate of bactericidal activity for Streptococcus faecalis of a new quinolone, CI-934, compared with that of amoxicillin.

Yourassowsky E, Van der Linden MP, Lismont MJ, Crokaert F, Glupczynski Y.

Antimicrob Agents Chemother. 1986 Aug;30(2):258-9.

45.

[Growth curves and killing rate of Haemophilus influenzae exposed to amoxicillin, cefaclor and cefotaxime].

Yourassowsky E, Van der Linden MP, Lismont MJ, Crokaert F, Glupczynski Y.

Pathol Biol (Paris). 1986 May;34(5):381-4. French.

PMID:
3534710
46.

In-vitro activity of pefloxacin compared to other antibiotics.

Yourassowsky E, Van der Linden MP, Crokaert F, Glupczynski Y.

J Antimicrob Chemother. 1986 Apr;17 Suppl B:19-28.

PMID:
3086279
47.

Multicenter in vitro study of the susceptibility of the Bacteroides fragilis group in Belgium.

Glupczynski Y, Yourassowsky E.

Acta Clin Belg. 1986;41(3):167-72. No abstract available.

PMID:
3766035
48.

Effect of mecillinam on Escherichia coli growth curves when given alone and associated with ampicillin.

Yourassowsky E, van der Linden MP, Lismont MJ, Crokaert F, Glupczynski Y.

Scand J Infect Dis. 1986;18(5):439-45.

PMID:
3535050
49.

Clinical evaluation of teicoplanin for therapy of severe infections caused by gram-positive bacteria.

Glupczynski Y, Lagast H, Van der Auwera P, Thys JP, Crokaert F, Yourassowsky E, Meunier-Carpentier F, Klastersky J, Kains JP, Serruys-Schoutens E, et al.

Antimicrob Agents Chemother. 1986 Jan;29(1):52-7.

50.

Correlation between growth curve and killing curve of Escherichia coli after a brief exposure to suprainhibitory concentrations of ampicillin and piperacillin.

Yourassowsky E, Van der Linden MP, Lismont MJ, Crokaert F, Glupczynski Y.

Antimicrob Agents Chemother. 1985 Dec;28(6):756-60.

Supplemental Content

Loading ...
Support Center